3.0
Jan 12, 2009
Former employee
Whitehouse Station, NJ
Recommend
CEO approval
Business outlook
Pros
Great Benefits. It used to be the #1 pharmaceutical, at least in most therapeutic areas where it had a product competing, and it might be #1 again, but not soon.
Cons
It is undergoing a major transformation, and most middle management (Sr. Directors, Directors, Managers) are trying to survive, even resisting change. New layoffs were announced for 2009, morale is low. Don't go to Comet, unless you enjoy pain.